|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/20 | |
| A61P 37/00 | |||
| A61P 37/06 |
| (11) | Number of the document | 2288372 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09741834.7 |
| Date of filing the European patent application | 2009-04-28 | |
| (97) | Date of publication of the European application | 2011-03-02 |
| (45) | Date of publication and mention of the grant of the patent | 2012-02-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/003076 |
| Date | 2009-04-28 |
| (87) | Number | WO 2009/135615 |
| Date | 2009-11-12 |
| (30) | Number | Date | Country code |
| 102008023820 | 2008-05-08 | DE |
| (72) |
PAULSEN, Daniela, DE
BRUNNER, Nina, DE
BRAY, Dorothy, GB
|
| (73) |
AiCuris GmbH & Co. KG,
Friedrich-Ebert-Strasse 475, 42117 Wuppertal,
DE
|
| (54) | EIN IL-2 MUTEIN ZUR BEHANDLUNG ODER PROPHYLAXE EINER AUTOIMMUNERKRANKUNG |
| AN IL-2 MUTANT FOR USE IN THE TREATMENT OR PROPHYLAXIS OF AUTOIMMUNE DISEASE |